Who to call at Travere Therapeutics, and when
Fundz watches for the moments Travere Therapeutics starts buying, and tells you who to reach.
- An alert the day Travere Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Travere Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Travere Therapeutics. With Fundz connected, it knows.
Contract Type
licensing
Description
On June 1, 2026, Travere Therapeutics entered into a license and collaboration agreement with Everest Medicines. Under the agreement, Everest grants an exclusive license to Travere for the development and commercialization of civorebrutinib and related products for various uses outside of China and select East and Southeast Asian countries. This collaboration aims to advance treatments utilizing the BTK inhibitor technology for numerous diseases and disorders.
Quick answer
Travere Therapeutics Enters License Agreement with Everest Medicines (June 2, 2026). Travere Therapeutics is based in San Diego, California, United States.
- What agreement did Travere Therapeutics announce on June 2, 2026?
- On June 1, 2026, Travere Therapeutics entered into a license and collaboration agreement with Everest Medicines. Under the agreement, Everest grants an exclusive license to Travere for the development and commercialization of civorebrutinib and related products for various uses outside of China and select East and Southeast Asian countries.
- What does Travere Therapeutics do?
- Travere Therapeutics, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for people living with rare diseases.
- Where is Travere Therapeutics based?
- Travere Therapeutics is based in San Diego, California, United States.
Source: Fundz verified event record.
Related People
Travere Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.